{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T02:04:09Z","timestamp":1785895449786,"version":"3.56.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T00:00:00Z","timestamp":1724112000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.bbi.2024.08.032","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T12:02:56Z","timestamp":1724414576000},"page":"497-509","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Targeting CNS myeloid infiltrates provides neuroprotection in a progressive multiple sclerosis model"],"prefix":"10.1016","volume":"122","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3567-9853","authenticated-orcid":false,"given":"Tal","family":"Ganz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Fainstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paschalis","family":"Theotokis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharona","family":"Elgavish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriya","family":"Vardi-Yaakov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marva","family":"Lachish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihi","family":"Sofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omri","family":"Zveik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Grigoriadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3463-2922","authenticated-orcid":false,"given":"Tamir","family":"Ben-Hur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2024.08.032_b0005","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0165-5728(90)90019-J","article-title":"Induction of chronic relapsing experimental allergic encephalomyelitis in Biozzi mice","volume":"28","author":"Baker","year":"1990","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2024.08.032_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2018.02.015","article-title":"The roles of macrophages and microglia in multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"318","author":"Chu","year":"2018","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2024.08.032_b0015","volume":"8","author":"de Barcelos","year":"2019","journal-title":"Mitochondrial Dysfunction and Multiple Sclerosis. Biology (basel)"},{"key":"10.1016\/j.bbi.2024.08.032_b0020","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/glia.20153","article-title":"Retinoic acid inhibits expression of TNF-\u03b1 and iNOS in activated rat microglia","volume":"50","author":"Dheen","year":"2005","journal-title":"Glia"},{"key":"10.1016\/j.bbi.2024.08.032_b0025","doi-asserted-by":"crossref","unstructured":"Faissner, S., Plemel, J. R., Gold, R. & Yong, V. W. Progressive multiple sclerosis: from pathophysiology to therapeutic strategies. Nature Reviews Drug Discovery vol. 18 Preprint at https:\/\/doi.org\/10.1038\/s41573-019-0035-2 (2019).","DOI":"10.1038\/s41573-019-0035-2"},{"key":"10.1016\/j.bbi.2024.08.032_b0030","doi-asserted-by":"crossref","unstructured":"Fischer, M. T. et al. NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury. A JOURNAL OF NEUROLOGY doi:10.1093\/brain\/aws012.","DOI":"10.1093\/brain\/aws012"},{"key":"10.1016\/j.bbi.2024.08.032_b0035","doi-asserted-by":"crossref","unstructured":"Fyfe, I. Mitochondrial DNA marks multiple sclerosis. Nature Reviews Neurology vol. 20 Preprint at https:\/\/doi.org\/10.1038\/s41582-024-00948-w (2024).","DOI":"10.1038\/s41582-024-00948-w"},{"key":"10.1016\/j.bbi.2024.08.032_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-021-02369-8","article-title":"Microbial pathogens induce neurodegeneration in Alzheimer\u2019s disease mice: protection by microglial regulation","volume":"19","author":"Ganz","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbi.2024.08.032_b0045","doi-asserted-by":"crossref","DOI":"10.1002\/glia.24453","article-title":"Oligodendrocyte progenitor cells differentiation induction with MAPK\/ERK inhibitor fails to support repair processes in the chronically demyelinated CNS","author":"Ganz","year":"2023","journal-title":"Glia"},{"key":"10.1016\/j.bbi.2024.08.032_b0050","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.nbd.2014.01.018","article-title":"Microglia activation in multiple sclerosis black holes predicts outcome in progressive patients: An in vivo [(11)C](R)-PK11195-PET pilot study","volume":"65","author":"Giannetti","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbi.2024.08.032_b0055","author":"Giusti","year":"2019","journal-title":"Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis."},{"key":"10.1016\/j.bbi.2024.08.032_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbi.2021.05.007","article-title":"Electric neurostimulation regulates microglial activation via retinoic acid receptor \u03b1 signaling","volume":"96","author":"Goldfarb","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2024.08.032_b0065","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.137028","article-title":"Electroconvulsive stimulation attenuates chronic neuroinflammation","volume":"5","author":"Goldfarb","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.bbi.2024.08.032_b0070","doi-asserted-by":"crossref","unstructured":"Hampton, D. W. et al. An experimental model of secondary progressive multiple sclerosis that shows regional variation in gliosis, remyelination, axonal and neuronal loss. (2008) doi:10.1016\/j.jneuroim.2008.05.034.","DOI":"10.1016\/j.jneuroim.2008.05.034"},{"key":"10.1016\/j.bbi.2024.08.032_b0075","doi-asserted-by":"crossref","unstructured":"Herz, J., Filiano, A. J., Yogev, N. & Kipnis, J. Myeloid Cells in the Central Nervous System. doi:10.1016\/j.immuni.2017.06.007.","DOI":"10.1016\/j.immuni.2017.06.007"},{"key":"10.1016\/j.bbi.2024.08.032_b0080","author":"Illes","year":"2019","journal-title":"Pathogenic Mechanisms Associated with Different Clinical Courses of Multiple Sclerosis."},{"key":"10.1016\/j.bbi.2024.08.032_b0085","doi-asserted-by":"crossref","unstructured":"Hao, Yuhan et al. \u201cIntegrated analysis of multimodal single-cell data.\u201d Cell vol. 184,13 (2021): 3573-3587.e29. doi:10.1016\/j.cell.2021.04.048.","DOI":"10.1016\/j.cell.2021.04.048"},{"key":"10.1016\/j.bbi.2024.08.032_b0090","doi-asserted-by":"crossref","unstructured":"Jord\u00e3o, M. J. C. et al. Neuroimmunology: Single-cell profiling identifies myeloid cell subsets with distinct fates during neuroinflammation. Science (1979) 363, (2019).","DOI":"10.1126\/science.aat7554"},{"key":"10.1016\/j.bbi.2024.08.032_b0095","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12974-022-02408-y","article-title":"Central nervous system macrophages in progressive multiple sclerosis: relationship to neurodegeneration and therapeutics","volume":"19","author":"Kamma","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbi.2024.08.032_b0100","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.03116","article-title":"Pathogenic Mechanisms Associated With Different Clinical Courses of Multiple Sclerosis","volume":"9","author":"Lassmann","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbi.2024.08.032_b0105","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1750-3639.2007.00064.x","article-title":"The Immunopathology of Multiple Sclerosis: An Overview","volume":"17","author":"Lassmann","year":"2007","journal-title":"Brain Pathol."},{"key":"10.1016\/j.bbi.2024.08.032_b0110","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1084\/jem.20042307","article-title":"The macrophage F4\/80 receptor is required for the induction of antigen-specific efferent regulatory T cells in peripheral tolerance","volume":"201","author":"Lin","year":"1615","journal-title":"The Journal of Experimental Medicine ARTICLE"},{"key":"10.1016\/j.bbi.2024.08.032_b0115","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-02787-4","article-title":"Mitochondrial levels determine variability in cell death by modulating apoptotic gene expression","volume":"9","author":"M\u00e1rquez-Jurado","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbi.2024.08.032_b0120","doi-asserted-by":"crossref","DOI":"10.1002\/glia.23936","article-title":"Myeloid-derived suppressor cells support remyelination in a murine model of multiple sclerosis by promoting oligodendrocyte precursor cell survival, proliferation, and differentiation","volume":"69","author":"Melero-Jerez","year":"2021","journal-title":"Glia"},{"key":"10.1016\/j.bbi.2024.08.032_b0125","doi-asserted-by":"crossref","unstructured":"Melis, M. et al. Effects of AM80 compared to AC261066 in a high fat diet mouse model of liver disease. (2019) doi:10.1371\/journal.pone.0211071.","DOI":"10.1371\/journal.pone.0211071"},{"key":"10.1016\/j.bbi.2024.08.032_b0130","article-title":"Myeloid cells \u2014 targets of medication in multiple sclerosis","author":"Mishra","year":"2016","journal-title":"Nat. Publ. Group"},{"key":"10.1016\/j.bbi.2024.08.032_b0135","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.nbd.2014.03.017","article-title":"The synthetic retinoid Am 80 delays recovery in a model of multiple sclerosis by modulating myeloid-derived suppressor cell fate and viability","volume":"67","author":"Molin\u00e9-Vel\u00e1zquez","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbi.2024.08.032_b0140","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.742065","article-title":"Microglia in Neuroinflammation and Neurodegeneration: From Understanding to Therapy","volume":"15","author":"Muzio","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bbi.2024.08.032_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577582","article-title":"Modeling compartmentalized chronic immune-mediated demyelinating CNS disease in the Biozzi ABH mouse","volume":"356","author":"Nishri","year":"2021","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2024.08.032_b0150","doi-asserted-by":"crossref","DOI":"10.1111\/sji.12963","article-title":"Protective roles for myeloid cells in neuroinflammation","volume":"92","author":"Owens","year":"2020","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.bbi.2024.08.032_b0155","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1146\/annurev-immunol-093019-110159","article-title":"Microglia and Central Nervous System-Associated Macrophages\u2014From Origin to Disease Modulation","volume":"39","author":"Prinz","year":"2021","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bbi.2024.08.032_b0160","doi-asserted-by":"crossref","unstructured":"Ruiz, F., Vigne, S. & Pot, C. Resolution of inflammation during multiple sclerosis. Seminars in Immunopathology vol. 41 Preprint at https:\/\/doi.org\/10.1007\/s00281-019-00765-0 (2019).","DOI":"10.1007\/s00281-019-00765-0"},{"key":"10.1016\/j.bbi.2024.08.032_b0165","doi-asserted-by":"crossref","DOI":"10.1038\/s41409-019-0684-0","volume":"55","author":"Sharrack","year":"2020","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbi.2024.08.032_b0170","doi-asserted-by":"crossref","unstructured":"Takaoka, Y. et al. Retinoic acid receptor agonist Am80 inhibits CXCL2 production from microglial BV-2 cells via attenuation of NF-\u03baB signaling. (2016) doi:10.1016\/j.intimp.2016.06.025.","DOI":"10.1016\/j.intimp.2016.06.025"},{"key":"10.1016\/j.bbi.2024.08.032_b0175","doi-asserted-by":"crossref","unstructured":"Xu, J. & Drew, P. D. 9-Cis-retinoic acid suppresses inflammatory responses of microglia and astrocytes. doi:10.1016\/j.jneuroim.2005.10.004.","DOI":"10.1016\/j.jneuroim.2005.10.004"},{"key":"10.1016\/j.bbi.2024.08.032_b0180","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/glia.24165","article-title":"Cerebrospinal fluid of progressive multiple sclerosis patients reduces differentiation and immune functions of oligodendrocyte progenitor cells","volume":"70","author":"Zveik","year":"2022","journal-title":"Glia"}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159124005579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159124005579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T03:58:33Z","timestamp":1739851113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159124005579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":36,"alternative-id":["S0889159124005579"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2024.08.032","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting CNS myeloid infiltrates provides neuroprotection in a progressive multiple sclerosis model","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2024.08.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}